Bioreactors have become irreplaceable tools in bioprocessing, revolutionizing the production of many biotechnological products. 1,2 They offer optimized and controlled environments to enhance cell ...

With the aid of artificial stem cells, it will soon be possible to establish new treatments for previously incurable diseases such as Alzheimer's disease. At the Fraunhofer Project Center for Stem ...

In this interview, learn how Raman spectroscopy is used as a Process Analytical Technology (PAT) in bioreactor monitoring and control for cultivated meat production. Why look at different ways to ...

Discover how bioprocessing technology industrial applications expand as fermentation, membrane filtration, PAT, and ...

The application makes the power of AI accessible to pharma manufacturing while preserving GxP compliance, enabling data-driven decisions faster in the pursuit of bioreactor process optimization.

Bioreactor makers should consider using additive manufacturing, also known as 3D printing, according to a study, which suggests the potential benefits of the approach would be worth the investment.

BETHLEHEM, Pa.--(BUSINESS WIRE)--ABEC, a global leader in engineered solutions and services for biotech manufacturing, has introduced its Advanced Therapy Bioreactor (ATB™) – a revolutionary platform ...

Single-use bioreactors are changing the biomolecular production landscape. Biologic drugs including monoclonal antibodies, therapeutic proteins, immunotherapies, and vaccines have transformed the ...

SOURCE WuXi PharmaTech (Cayman) Inc. SHANGHAI and TAIPEI, Oct. 30, 2013 - WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing ...

Researchers have developed a novel method capable of producing clinical doses of viable autologous chimeric antigen receptor (CAR) T-cells in a ultra-small automated closed-system microfluidic chip, ...

WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its MFG17 drug substance facility located at the Shanghai Fengxian site ...